People with specific combinations of genetic variants in the USF1 and LIPC genes have been observed to have higher levels of fat in their liver, as measured by a specialized imaging technique, which...
Mechanism
Synthesis from 1 study
Certain gene versions work together to make the liver less able to break down fat in the blood, so that fat builds up inside the liver instead. This happens because the liver makes less of a key enzyme that normally clears fat from the bloodstream.
Most probable mechanism
When two specific versions of the USF1 gene are present together with a particular version of the LIPC gene, the liver makes less of an enzyme that breaks down fat in the blood. This causes more fat to build up in the liver instead of being cleared away.
USF1 transcription factor binds to the promoter region of the LIPC gene and regulates its expression in hepatocytes.
The LIPC -514C>T T allele reduces hepatic lipase enzyme activity or expression, decreasing the hydrolysis of triglycerides in circulating lipoproteins.
Homozygosity for the major alleles of USF1 usf1s1 and usf1s2 enhances the regulatory effect of USF1 on LIPC, but in combination with the LIPC -514T allele, this leads to a net reduction in functional hepatic lipase.
Reduced hepatic lipase activity results in accumulation of triglyceride-rich lipoproteins in circulation, increasing hepatic uptake of free fatty acids and promoting intracellular triglyceride storage.
Increased hepatic triglyceride accumulation manifests as elevated liver fat content measured by proton magnetic resonance spectroscopy.
Less supported by current evidence, but not ruled out
Certain versions of the USF1 gene make the body more sensitive to insulin's ability to stop fat breakdown in fat tissue. This causes fewer fatty acids to be released into the blood, but paradoxically, more fatty acids end up in the liver because of how the liver handles fat.
USF1 polymorphisms (usf1s1 T allele and usf1s2 A allele) increase transcriptional regulation of hormone-sensitive lipase (HSL) in adipocytes.
Increased USF1 activity enhances insulin's ability to suppress adipose tissue lipolysis, reducing circulating free fatty acid levels during glucose challenge.
Reduced systemic free fatty acid flux alters hepatic lipid partitioning, favoring re-esterification and storage of fatty acids derived from de novo lipogenesis or remnant lipoproteins.
This shift in lipid flux contributes to hepatic triglyceride accumulation independent of hepatic lipase activity.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.